Source:http://linkedlifedata.com/resource/pubmed/id/21041295
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
53
|
pubmed:dateCreated |
2010-12-27
|
pubmed:abstractText |
Like most metalloproteases, matrix metalloprotease 2 (MMP-2) is synthesized as a zymogen. MMP-2 propeptide plays a role in inhibition of catalytic activity through a cysteine-zinc ion pairing, disruption of which results in full enzyme activation. A variety of proteases have been shown to be involved in the activation of pro-MMP-2, including metalloproteases and serine proteases. In the previous study we showed that MMP-2 activation occurred via specific cleavages of the propeptide by thrombin followed by intermolecular autoproteolytic processing for full enzymatic activity. Thrombin also degraded MMP-2, but this degradation was reduced greatly under cell-associated conditions with a concomitant increase in activation, prompting us to elucidate the molecular mechanisms underlying thrombin-mediated MMP-2 activation. In the present study we demonstrate that heparan sulfate is essential for thrombin-mediated activation of pro-MMP-2. Binding of heparan sulfate to thrombin is primarily responsible for this activation process, presumably through conformational changes at the active site. Furthermore, interaction of MMP-2 with exosites 1 and 2 of thrombin is crucial for thrombin-mediated MMP-2 degradation, and inhibition of this interaction by heparan sulfate or hirudin fragment results in a decrease in MMP-2 degradation. Finally, we demonstrated interaction between exosite 1 and hemopexin-like domain of MMP-2, suggesting a regulatory role of hemopexin-like domain in MMP-2 degradation. Taken together, our experimental data suggest a novel regulatory mechanism of thrombin-dependent MMP-2 enzymatic activity by heparan sulfate proteoglycans.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1083-351X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
31
|
pubmed:volume |
285
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41270-9
|
pubmed:meshHeading |
pubmed-meshheading:21041295-Animals,
pubmed-meshheading:21041295-Binding Sites,
pubmed-meshheading:21041295-Brain,
pubmed-meshheading:21041295-COS Cells,
pubmed-meshheading:21041295-Cell Line, Tumor,
pubmed-meshheading:21041295-Cercopithecus aethiops,
pubmed-meshheading:21041295-Hemopexin,
pubmed-meshheading:21041295-Heparitin Sulfate,
pubmed-meshheading:21041295-Humans,
pubmed-meshheading:21041295-K562 Cells,
pubmed-meshheading:21041295-Matrix Metalloproteinase 2,
pubmed-meshheading:21041295-Mutation,
pubmed-meshheading:21041295-Protein Conformation,
pubmed-meshheading:21041295-Protein Structure, Tertiary,
pubmed-meshheading:21041295-Thrombin
|
pubmed:year |
2010
|
pubmed:articleTitle |
Thrombin-dependent MMP-2 activity is regulated by heparan sulfate.
|
pubmed:affiliation |
Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Korea. k4119@yonsei.ac.kr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|